<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b0a145d4-47af-40e6-be53-458434972721,g:73290b73-fa33-409e-983d-8b6098348629-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Cover" xlink:type="simple" xlink:href="jazz-20200930.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSENEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="jazz-20200930.xsd#CONDENSENEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CONDENSENEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1ea9056a-4989-4316-8336-691dcb26b3cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_75abae66-7118-44d4-8f7a-44169e073cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1ea9056a-4989-4316-8336-691dcb26b3cb" xlink:to="loc_us-gaap_AccountsPayableCurrent_75abae66-7118-44d4-8f7a-44169e073cbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a7de4bd3-dd00-4eef-9614-80b5af68c2d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1ea9056a-4989-4316-8336-691dcb26b3cb" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a7de4bd3-dd00-4eef-9614-80b5af68c2d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_822f495a-de28-434b-a53a-076792f110bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1ea9056a-4989-4316-8336-691dcb26b3cb" xlink:to="loc_us-gaap_LongTermDebtCurrent_822f495a-de28-434b-a53a-076792f110bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_e922bf5e-59b7-46b7-9782-394db39b446f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1ea9056a-4989-4316-8336-691dcb26b3cb" xlink:to="loc_us-gaap_TaxesPayableCurrent_e922bf5e-59b7-46b7-9782-394db39b446f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5edab1a8-a29b-46ac-8ad8-7f20b3832cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1ea9056a-4989-4316-8336-691dcb26b3cb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5edab1a8-a29b-46ac-8ad8-7f20b3832cd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6d39e158-aec5-4187-8ac8-9a40d3597677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d16c1174-e6f6-4696-9a72-223a58142476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6d39e158-aec5-4187-8ac8-9a40d3597677" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d16c1174-e6f6-4696-9a72-223a58142476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_06db190e-5154-4045-97f5-3bd5f859c399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6d39e158-aec5-4187-8ac8-9a40d3597677" xlink:to="loc_us-gaap_Investments_06db190e-5154-4045-97f5-3bd5f859c399" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d70bf8df-7007-47f7-9f9a-357ba7ef28c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6d39e158-aec5-4187-8ac8-9a40d3597677" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d70bf8df-7007-47f7-9f9a-357ba7ef28c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4dc01ddd-7fda-46d3-91b1-5a6eb9b87a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6d39e158-aec5-4187-8ac8-9a40d3597677" xlink:to="loc_us-gaap_InventoryNet_4dc01ddd-7fda-46d3-91b1-5a6eb9b87a3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_ab4b92fc-2893-4d30-892a-a8047b6100da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6d39e158-aec5-4187-8ac8-9a40d3597677" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_ab4b92fc-2893-4d30-892a-a8047b6100da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_cfeddd82-df15-4d35-a989-68821d60c2f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6d39e158-aec5-4187-8ac8-9a40d3597677" xlink:to="loc_us-gaap_OtherAssetsCurrent_cfeddd82-df15-4d35-a989-68821d60c2f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e6c916bb-93cc-43a9-8546-98a98d8a3c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d47f0c4b-90b9-450d-abd0-98ecadd3c55d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e6c916bb-93cc-43a9-8546-98a98d8a3c2c" xlink:to="loc_us-gaap_LiabilitiesCurrent_d47f0c4b-90b9-450d-abd0-98ecadd3c55d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_16c4a61e-7fe7-453d-8a6e-14b857700238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e6c916bb-93cc-43a9-8546-98a98d8a3c2c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_16c4a61e-7fe7-453d-8a6e-14b857700238" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3d23fdbe-5732-450c-965d-631c32f4f79e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e6c916bb-93cc-43a9-8546-98a98d8a3c2c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3d23fdbe-5732-450c-965d-631c32f4f79e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_16ac3ea8-0904-4dfe-a540-31ab2ea8d90e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e6c916bb-93cc-43a9-8546-98a98d8a3c2c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_16ac3ea8-0904-4dfe-a540-31ab2ea8d90e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_84474792-e82d-4e36-b129-9ec87ea18c49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e6c916bb-93cc-43a9-8546-98a98d8a3c2c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_84474792-e82d-4e36-b129-9ec87ea18c49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c0d14de7-21ad-4826-903e-0230866ca3ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e6c916bb-93cc-43a9-8546-98a98d8a3c2c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c0d14de7-21ad-4826-903e-0230866ca3ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_fa1b358a-31a0-4834-8040-e79d80789cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e6c916bb-93cc-43a9-8546-98a98d8a3c2c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_fa1b358a-31a0-4834-8040-e79d80789cb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c828f175-02f3-44b0-bd5f-bf7006d8c4bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e6c916bb-93cc-43a9-8546-98a98d8a3c2c" xlink:to="loc_us-gaap_StockholdersEquity_c828f175-02f3-44b0-bd5f-bf7006d8c4bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3625cb00-f78e-4e87-9d5f-1568cbc01e22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e6c53668-9bbf-409e-b81d-b3b6af0ebda4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3625cb00-f78e-4e87-9d5f-1568cbc01e22" xlink:to="loc_us-gaap_AssetsCurrent_e6c53668-9bbf-409e-b81d-b3b6af0ebda4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f563d6ad-a8c3-4aab-b178-cb9bbe65af7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3625cb00-f78e-4e87-9d5f-1568cbc01e22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f563d6ad-a8c3-4aab-b178-cb9bbe65af7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6b41da42-8ed9-420b-b461-d316023313b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3625cb00-f78e-4e87-9d5f-1568cbc01e22" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6b41da42-8ed9-420b-b461-d316023313b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b838b4b0-6d42-4b34-a6f7-b1dc23a14ace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3625cb00-f78e-4e87-9d5f-1568cbc01e22" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b838b4b0-6d42-4b34-a6f7-b1dc23a14ace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_db6c5441-e559-4a96-9862-f5e82b72c94a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3625cb00-f78e-4e87-9d5f-1568cbc01e22" xlink:to="loc_us-gaap_Goodwill_db6c5441-e559-4a96-9862-f5e82b72c94a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ba7fe918-e331-4f16-8f7d-d9a939b784fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3625cb00-f78e-4e87-9d5f-1568cbc01e22" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ba7fe918-e331-4f16-8f7d-d9a939b784fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_25de1198-5f1f-4c6e-930a-fa9b28815ee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3625cb00-f78e-4e87-9d5f-1568cbc01e22" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_25de1198-5f1f-4c6e-930a-fa9b28815ee1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_16caecb0-51a1-41a5-a4e9-09d6299bf852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_3625cb00-f78e-4e87-9d5f-1568cbc01e22" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_16caecb0-51a1-41a5-a4e9-09d6299bf852" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c175cee4-e0da-4312-8e00-c3715d49c13a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_1124e924-5b8c-48e4-a59e-759cbc700334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c175cee4-e0da-4312-8e00-c3715d49c13a" xlink:to="loc_us-gaap_CommonStockValue_1124e924-5b8c-48e4-a59e-759cbc700334" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NonvotingEuroDeferredShares_f079e3ec-86a7-43d5-89f9-91f5431d7a11" xlink:href="jazz-20200930.xsd#jazz_NonvotingEuroDeferredShares"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c175cee4-e0da-4312-8e00-c3715d49c13a" xlink:to="loc_jazz_NonvotingEuroDeferredShares_f079e3ec-86a7-43d5-89f9-91f5431d7a11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CapitalRedemptionReserve_2eaf27d4-8340-4670-9f35-dab7158c619e" xlink:href="jazz-20200930.xsd#jazz_CapitalRedemptionReserve"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c175cee4-e0da-4312-8e00-c3715d49c13a" xlink:to="loc_jazz_CapitalRedemptionReserve_2eaf27d4-8340-4670-9f35-dab7158c619e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5b805cbc-7e60-4192-baee-dab5705d5d20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c175cee4-e0da-4312-8e00-c3715d49c13a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5b805cbc-7e60-4192-baee-dab5705d5d20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8a52ce26-ff06-47df-a266-3a351171fd7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c175cee4-e0da-4312-8e00-c3715d49c13a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8a52ce26-ff06-47df-a266-3a351171fd7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3c8552a5-f782-4fe8-9de7-b83e6b875fd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c175cee4-e0da-4312-8e00-c3715d49c13a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3c8552a5-f782-4fe8-9de7-b83e6b875fd7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="jazz-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bc05bdd6-a4e1-494d-a6ab-22e26d9bcbeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9a8820b2-973e-4104-964d-29de5315676c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bc05bdd6-a4e1-494d-a6ab-22e26d9bcbeb" xlink:to="loc_us-gaap_OperatingIncomeLoss_9a8820b2-973e-4104-964d-29de5315676c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_22be5f89-faac-42e0-9317-0e5978a3ace4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bc05bdd6-a4e1-494d-a6ab-22e26d9bcbeb" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_22be5f89-faac-42e0-9317-0e5978a3ace4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_81d90ad5-43b3-4f99-a69d-f6f66341e56d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bc05bdd6-a4e1-494d-a6ab-22e26d9bcbeb" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_81d90ad5-43b3-4f99-a69d-f6f66341e56d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a6c1f6dd-9615-45d9-8cdf-d64233906e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ef20aa48-c82a-46ee-9613-8c841c4c57b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a6c1f6dd-9615-45d9-8cdf-d64233906e12" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ef20aa48-c82a-46ee-9613-8c841c4c57b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b9ad251d-33df-4d27-bcd0-4c5acbd29a30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a6c1f6dd-9615-45d9-8cdf-d64233906e12" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b9ad251d-33df-4d27-bcd0-4c5acbd29a30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a7ad9657-6fee-466e-ba32-7ddca722f379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a6c1f6dd-9615-45d9-8cdf-d64233906e12" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a7ad9657-6fee-466e-ba32-7ddca722f379" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7663bde8-0e28-4f02-9ab4-d4a9b170da4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0292f21-323a-47d4-9429-c5c4e8d35415" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7663bde8-0e28-4f02-9ab4-d4a9b170da4d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b0292f21-323a-47d4-9429-c5c4e8d35415" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_a8cf7da0-d661-4e00-a870-1c879f5ba694" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7663bde8-0e28-4f02-9ab4-d4a9b170da4d" xlink:to="loc_us-gaap_CostsAndExpenses_a8cf7da0-d661-4e00-a870-1c879f5ba694" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_2a9c4bfe-29d0-4638-8026-6f2af6a15b6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_399cc4ba-17f1-45e7-9b0b-b20c3385fea3" xlink:href="jazz-20200930.xsd#jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2a9c4bfe-29d0-4638-8026-6f2af6a15b6d" xlink:to="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_399cc4ba-17f1-45e7-9b0b-b20c3385fea3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f9534c0a-75c6-436b-817c-42e3f903fe71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2a9c4bfe-29d0-4638-8026-6f2af6a15b6d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f9534c0a-75c6-436b-817c-42e3f903fe71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_a23983ee-56bb-495d-8b2c-129d4e6f9bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2a9c4bfe-29d0-4638-8026-6f2af6a15b6d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_a23983ee-56bb-495d-8b2c-129d4e6f9bf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_fd9ac6c2-8d73-424d-80d4-0ce6b15e51b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2a9c4bfe-29d0-4638-8026-6f2af6a15b6d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_fd9ac6c2-8d73-424d-80d4-0ce6b15e51b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_548a687b-fd25-455d-b188-1b6902928f57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2a9c4bfe-29d0-4638-8026-6f2af6a15b6d" xlink:to="loc_us-gaap_AssetImpairmentCharges_548a687b-fd25-455d-b188-1b6902928f57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_d07fcafa-3b43-4d8a-85d1-cf7969280f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_2a9c4bfe-29d0-4638-8026-6f2af6a15b6d" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_d07fcafa-3b43-4d8a-85d1-cf7969280f6a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="jazz-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4c959266-0a7d-45c5-b01f-8bfb7e7b4ca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fe04f359-b21a-4085-b2e0-8391f045c623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4c959266-0a7d-45c5-b01f-8bfb7e7b4ca4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fe04f359-b21a-4085-b2e0-8391f045c623" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_f0c807a1-4c09-4ff0-a11c-1eb8bcf78101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4c959266-0a7d-45c5-b01f-8bfb7e7b4ca4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_f0c807a1-4c09-4ff0-a11c-1eb8bcf78101" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6429fe62-2fa4-4cbb-b0c8-1d5752bdccde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cabe9e24-faf5-4111-a1e2-d9f5fe142810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6429fe62-2fa4-4cbb-b0c8-1d5752bdccde" xlink:to="loc_us-gaap_NetIncomeLoss_cabe9e24-faf5-4111-a1e2-d9f5fe142810" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d72b3df1-968a-4ce9-a129-961584e2efbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6429fe62-2fa4-4cbb-b0c8-1d5752bdccde" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d72b3df1-968a-4ce9-a129-961584e2efbc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSParenthetical" xlink:type="simple" xlink:href="jazz-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSParenthetical"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="jazz-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="jazz-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d7710710-3708-46f6-8ce3-1758c56aabc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a49ac276-434a-4855-8661-58235b8a6ad8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d7710710-3708-46f6-8ce3-1758c56aabc8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a49ac276-434a-4855-8661-58235b8a6ad8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c62548bb-0d95-4ec2-ac67-de0ff43d2d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d7710710-3708-46f6-8ce3-1758c56aabc8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c62548bb-0d95-4ec2-ac67-de0ff43d2d1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01dd2411-005e-4317-aeed-3fc3cd2fc210" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d7710710-3708-46f6-8ce3-1758c56aabc8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01dd2411-005e-4317-aeed-3fc3cd2fc210" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b6eddd3f-8ee9-4a9f-91b8-5a54436789de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d7710710-3708-46f6-8ce3-1758c56aabc8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b6eddd3f-8ee9-4a9f-91b8-5a54436789de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_17ee3d0e-95f0-4dca-9727-dcd3f33aaf46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_5eedd14b-172b-4b72-bfe5-04d03361cc2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_17ee3d0e-95f0-4dca-9727-dcd3f33aaf46" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_5eedd14b-172b-4b72-bfe5-04d03361cc2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e96d5625-f775-4674-bec9-ddef942673d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_17ee3d0e-95f0-4dca-9727-dcd3f33aaf46" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e96d5625-f775-4674-bec9-ddef942673d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_785c2ed5-397a-4bc9-a066-c72da9faa675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_17ee3d0e-95f0-4dca-9727-dcd3f33aaf46" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_785c2ed5-397a-4bc9-a066-c72da9faa675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_614256d3-3443-4118-bd47-00bd98813f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_17ee3d0e-95f0-4dca-9727-dcd3f33aaf46" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_614256d3-3443-4118-bd47-00bd98813f7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c750f117-098a-4712-8480-a11d3e855e1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_17ee3d0e-95f0-4dca-9727-dcd3f33aaf46" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c750f117-098a-4712-8480-a11d3e855e1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_a979a69d-423e-41f5-9e2a-b0012bba9c22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_17ee3d0e-95f0-4dca-9727-dcd3f33aaf46" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_a979a69d-423e-41f5-9e2a-b0012bba9c22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_9131a82f-c4f0-412e-a8d1-00492c27693b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_17ee3d0e-95f0-4dca-9727-dcd3f33aaf46" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_9131a82f-c4f0-412e-a8d1-00492c27693b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_852c7786-5698-45de-bb46-550d3510b0c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_17ee3d0e-95f0-4dca-9727-dcd3f33aaf46" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_852c7786-5698-45de-bb46-550d3510b0c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a61b5ad8-c8fa-4904-8e52-163fac875262" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_NetIncomeLoss_a61b5ad8-c8fa-4904-8e52-163fac875262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6323a86e-56cb-4002-b6f0-c915df9edb40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6323a86e-56cb-4002-b6f0-c915df9edb40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a6c62c6e-e7b9-417b-b7f1-4116113af762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_ShareBasedCompensation_a6c62c6e-e7b9-417b-b7f1-4116113af762" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_d9dec07d-6d41-490f-9ec7-25cb0d6d246b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_AssetImpairmentCharges_d9dec07d-6d41-490f-9ec7-25cb0d6d246b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_af3a6ed9-d20c-4da8-8cb3-acbdca20dd4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_Depreciation_af3a6ed9-d20c-4da8-8cb3-acbdca20dd4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_2f61c7b6-fdde-4085-af0e-d676ec6874a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_2f61c7b6-fdde-4085-af0e-d676ec6874a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9635454c-f9f6-4fdd-bb10-28eac77fcf96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9635454c-f9f6-4fdd-bb10-28eac77fcf96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProvisionForLossesOnAccountsReceivableAndInventory_4d998927-bdeb-4ca3-90fb-611529b019ff" xlink:href="jazz-20200930.xsd#jazz_ProvisionForLossesOnAccountsReceivableAndInventory"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_jazz_ProvisionForLossesOnAccountsReceivableAndInventory_4d998927-bdeb-4ca3-90fb-611529b019ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1511035a-72ac-45cd-a3c1-4c5a9b816211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1511035a-72ac-45cd-a3c1-4c5a9b816211" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_d99b236b-4684-471b-aa98-401edf3e6d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_d99b236b-4684-471b-aa98-401edf3e6d0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1cb6f48e-96b2-4e6e-8372-16f07ec2c3be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1cb6f48e-96b2-4e6e-8372-16f07ec2c3be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3aecb7f6-352c-4898-a445-23be7f47ec14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3aecb7f6-352c-4898-a445-23be7f47ec14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1e8bbe11-050d-4cea-b988-174c4120de32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1e8bbe11-050d-4cea-b988-174c4120de32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_c7843a23-6ee5-48b7-8166-5c10b3018a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_c7843a23-6ee5-48b7-8166-5c10b3018a24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_IncreaseDecreaseInOperatingLeaseAssets_56cfe363-03a7-4747-ab4d-a439c2c92c91" xlink:href="jazz-20200930.xsd#jazz_IncreaseDecreaseInOperatingLeaseAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_jazz_IncreaseDecreaseInOperatingLeaseAssets_56cfe363-03a7-4747-ab4d-a439c2c92c91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8388b916-b588-4bd5-bfcd-0f90872ec251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8388b916-b588-4bd5-bfcd-0f90872ec251" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_926db01c-edb2-4717-94fd-a23047338ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_926db01c-edb2-4717-94fd-a23047338ff8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_370e03ef-d381-45a7-8072-7827c04b8d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_370e03ef-d381-45a7-8072-7827c04b8d00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_cbd2a098-3ae8-4889-a10d-2d18a59401fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_cbd2a098-3ae8-4889-a10d-2d18a59401fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_93781748-50a8-499b-83a7-45f4514b39f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_93781748-50a8-499b-83a7-45f4514b39f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent_3c228abe-1cb1-40ac-80a1-a05f14a4f3ab" xlink:href="jazz-20200930.xsd#jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent_3c228abe-1cb1-40ac-80a1-a05f14a4f3ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5ab5546c-4299-490f-8edd-5b8e3901d254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="22" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ad3e7db-54e8-41c4-ab2f-626308460bf2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_5ab5546c-4299-490f-8edd-5b8e3901d254" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_29b09ad1-b8db-4f3a-8923-2326f4533357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_78b75b19-bd55-41f6-bac5-6dce3a67ae36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_29b09ad1-b8db-4f3a-8923-2326f4533357" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_78b75b19-bd55-41f6-bac5-6dce3a67ae36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0255447f-4e26-46c3-b4dc-bc60b6583936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_29b09ad1-b8db-4f3a-8923-2326f4533357" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0255447f-4e26-46c3-b4dc-bc60b6583936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination_eb8719c4-d2db-4a5c-8198-d3a68a9c03a2" xlink:href="jazz-20200930.xsd#jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_29b09ad1-b8db-4f3a-8923-2326f4533357" xlink:to="loc_jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination_eb8719c4-d2db-4a5c-8198-d3a68a9c03a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b05572da-ba1a-4866-8e62-28b8fe14de71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_29b09ad1-b8db-4f3a-8923-2326f4533357" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b05572da-ba1a-4866-8e62-28b8fe14de71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_fb72c438-f868-433a-b256-6869f543d49c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_29b09ad1-b8db-4f3a-8923-2326f4533357" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_fb72c438-f868-433a-b256-6869f543d49c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PaymentToAcquireAssetsNetOfCashAcquired_0ec51b04-9e42-49a8-8984-33a6a50b035c" xlink:href="jazz-20200930.xsd#jazz_PaymentToAcquireAssetsNetOfCashAcquired"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_29b09ad1-b8db-4f3a-8923-2326f4533357" xlink:to="loc_jazz_PaymentToAcquireAssetsNetOfCashAcquired_0ec51b04-9e42-49a8-8984-33a6a50b035c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="jazz-20200930.xsd#TheCompanyandSummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jazz-20200930.xsd#TheCompanyandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesBasisofPresentationNarrativeDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#TheCompanyandSummaryofSignificantAccountingPoliciesBasisofPresentationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesBasisofPresentationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesConcentrationsofRiskNarrativeDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#TheCompanyandSummaryofSignificantAccountingPoliciesConcentrationsofRiskNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesConcentrationsofRiskNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LicenseAgreement" xlink:type="simple" xlink:href="jazz-20200930.xsd#LicenseAgreement"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LicenseAgreement" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LicenseAgreementNarrativeDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#LicenseAgreementNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LicenseAgreementNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecurities" xlink:type="simple" xlink:href="jazz-20200930.xsd#CashandAvailableforSaleSecurities"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecurities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesTables" xlink:type="simple" xlink:href="jazz-20200930.xsd#CashandAvailableforSaleSecuritiesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f7a058e1-7dc6-4045-8b60-a729ecf92f0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b36366b3-3275-46b4-bfc7-aa860c9aea5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f7a058e1-7dc6-4045-8b60-a729ecf92f0a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b36366b3-3275-46b4-bfc7-aa860c9aea5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c3a04453-1d64-4940-ae4a-ece1fac4175c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f7a058e1-7dc6-4045-8b60-a729ecf92f0a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c3a04453-1d64-4940-ae4a-ece1fac4175c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7ea61358-8a91-4637-9186-539e036e725a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f7a058e1-7dc6-4045-8b60-a729ecf92f0a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7ea61358-8a91-4637-9186-539e036e725a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#CashandAvailableforSaleSecuritiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="jazz-20200930.xsd#FairValueMeasurement"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurement" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="jazz-20200930.xsd#FairValueMeasurementTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_8e04367c-3b26-456d-990c-7ff0cc2a84c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_2a80c4c7-8e0a-40d6-aaf5-cfff14332994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_8e04367c-3b26-456d-990c-7ff0cc2a84c5" xlink:to="loc_us-gaap_DerivativeLiabilities_2a80c4c7-8e0a-40d6-aaf5-cfff14332994" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_5b5d2153-b64b-4330-9b19-3a56f7e090fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fa0897b7-43bb-4fa6-a103-238e09aa48dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_5b5d2153-b64b-4330-9b19-3a56f7e090fd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fa0897b7-43bb-4fa6-a103-238e09aa48dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_347417cd-73f0-4aba-92b2-b7274012662f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_5b5d2153-b64b-4330-9b19-3a56f7e090fd" xlink:to="loc_us-gaap_DerivativeAssets_347417cd-73f0-4aba-92b2-b7274012662f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="simple" xlink:href="jazz-20200930.xsd#DerivativeInstrumentsandHedgingActivities"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="jazz-20200930.xsd#DerivativeInstrumentsandHedgingActivitiesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesGainsonDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#DerivativeInstrumentsandHedgingActivitiesGainsonDerivativeInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesGainsonDerivativeInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#DerivativeInstrumentsandHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesFairValueofOutstandingDerivativesDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#DerivativeInstrumentsandHedgingActivitiesFairValueofOutstandingDerivativesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesFairValueofOutstandingDerivativesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_d0cdd227-12d6-4a37-94e8-0218b291b54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_c1328b38-3090-4c8e-a54a-b7be6c95c3bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_d0cdd227-12d6-4a37-94e8-0218b291b54a" xlink:to="loc_us-gaap_DerivativeAssets_c1328b38-3090-4c8e-a54a-b7be6c95c3bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_c58f180a-4ab1-4b3c-b43b-107672771016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_d0cdd227-12d6-4a37-94e8-0218b291b54a" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_c58f180a-4ab1-4b3c-b43b-107672771016" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_9fef6e02-3cfc-473e-9222-64502b4f68c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_d0cdd227-12d6-4a37-94e8-0218b291b54a" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_9fef6e02-3cfc-473e-9222-64502b4f68c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_6e459edb-7e9c-49de-9730-1e35930c06bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_0bc8b102-c5ac-471a-9fa9-480048d191ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_6e459edb-7e9c-49de-9730-1e35930c06bb" xlink:to="loc_us-gaap_DerivativeLiabilities_0bc8b102-c5ac-471a-9fa9-480048d191ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimSecurities_8897a9c6-3481-4a58-85a7-364ff72a8ac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_6e459edb-7e9c-49de-9730-1e35930c06bb" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimSecurities_8897a9c6-3481-4a58-85a7-364ff72a8ac1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_0a37919f-e834-47bd-83ce-e7f3a8e2fb7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_6e459edb-7e9c-49de-9730-1e35930c06bb" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_0a37919f-e834-47bd-83ce-e7f3a8e2fb7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_31b85083-161f-41f9-9320-77b2ba697459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_8b87e664-e18e-4e1b-9d74-51f1086993a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_31b85083-161f-41f9-9320-77b2ba697459" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_8b87e664-e18e-4e1b-9d74-51f1086993a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_c8acd9ee-f21e-4bdd-888e-a70849b00de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_31b85083-161f-41f9-9320-77b2ba697459" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_c8acd9ee-f21e-4bdd-888e-a70849b00de6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_1b8f4528-aa87-4bf1-9b6d-85927b552871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6900d8a6-0d88-44eb-8eb4-8988fd136d89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_1b8f4528-aa87-4bf1-9b6d-85927b552871" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6900d8a6-0d88-44eb-8eb4-8988fd136d89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_6515a2b1-fcb6-4c20-b05f-3b5b5af85c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_1b8f4528-aa87-4bf1-9b6d-85927b552871" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_6515a2b1-fcb6-4c20-b05f-3b5b5af85c2e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Inventories" xlink:type="simple" xlink:href="jazz-20200930.xsd#Inventories"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Inventories" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/InventoriesTables" xlink:type="simple" xlink:href="jazz-20200930.xsd#InventoriesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/InventoriesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/InventoriesComponentsofInventoriesDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#InventoriesComponentsofInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/InventoriesComponentsofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_be94447f-10f5-4e63-83d1-13cd9b381e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_e83aadfd-da5c-4765-9b6c-ac7d0cfb5a92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_be94447f-10f5-4e63-83d1-13cd9b381e9e" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_e83aadfd-da5c-4765-9b6c-ac7d0cfb5a92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8e701750-2118-457b-83fc-bc60ef1d9f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_be94447f-10f5-4e63-83d1-13cd9b381e9e" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_8e701750-2118-457b-83fc-bc60ef1d9f05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5514530f-b3e5-4739-9074-78493db3635c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_be94447f-10f5-4e63-83d1-13cd9b381e9e" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5514530f-b3e5-4739-9074-78493db3635c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="jazz-20200930.xsd#GoodwillandIntangibleAssets"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="jazz-20200930.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGoodwillActivityDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#GoodwillandIntangibleAssetsGoodwillActivityDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGoodwillActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4cf92872-6295-49f9-89ad-a9ed74dcb954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5986d3e2-5a2b-4076-9e45-0769e2236f19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4cf92872-6295-49f9-89ad-a9ed74dcb954" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5986d3e2-5a2b-4076-9e45-0769e2236f19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c6a735b3-c6ce-482b-a30d-69e1f3281bb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4cf92872-6295-49f9-89ad-a9ed74dcb954" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c6a735b3-c6ce-482b-a30d-69e1f3281bb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a58d108d-3735-40a1-8e5f-a2af08246cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5de88002-a877-49f8-b263-12025db8ca7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a58d108d-3735-40a1-8e5f-a2af08246cdd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5de88002-a877-49f8-b263-12025db8ca7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b17ceeec-1ab2-4e46-a08c-798e2d2298b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a58d108d-3735-40a1-8e5f-a2af08246cdd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b17ceeec-1ab2-4e46-a08c-798e2d2298b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8b203cfa-b057-47af-8e74-5bba092a8fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2f08c864-d356-4b61-9e30-3a7cabed0f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8b203cfa-b057-47af-8e74-5bba092a8fb5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2f08c864-d356-4b61-9e30-3a7cabed0f5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5d7f692e-9af5-4efe-96c8-8fe623e30596" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8b203cfa-b057-47af-8e74-5bba092a8fb5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5d7f692e-9af5-4efe-96c8-8fe623e30596" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="jazz-20200930.xsd#GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_41895776-387f-43e8-a6bc-1580c81baffb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1d723cb8-a667-4cf5-905e-bf8a6f28c932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_41895776-387f-43e8-a6bc-1580c81baffb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1d723cb8-a667-4cf5-905e-bf8a6f28c932" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_56b7a9a5-2c3a-459d-aa55-8a606f530c42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_41895776-387f-43e8-a6bc-1580c81baffb" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_56b7a9a5-2c3a-459d-aa55-8a606f530c42" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationCostsDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#GoodwillandIntangibleAssetsEstimatedFutureAmortizationCostsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_25d36008-3d8c-4baf-8831-71e92da75d97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_bc1a5078-fac3-414c-a25f-b1a51fe0ed1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_25d36008-3d8c-4baf-8831-71e92da75d97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_bc1a5078-fac3-414c-a25f-b1a51fe0ed1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_61f4bbd6-9bb9-4da5-a3e8-13ee8317ce42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_25d36008-3d8c-4baf-8831-71e92da75d97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_61f4bbd6-9bb9-4da5-a3e8-13ee8317ce42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7f254a6f-3c49-4120-9908-1ff5269b9a63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_25d36008-3d8c-4baf-8831-71e92da75d97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7f254a6f-3c49-4120-9908-1ff5269b9a63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_fbc16c83-fb61-4c79-9746-84185fdc4e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_25d36008-3d8c-4baf-8831-71e92da75d97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_fbc16c83-fb61-4c79-9746-84185fdc4e84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_48313bf3-fafa-481e-91ad-1c4afd62ec16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_25d36008-3d8c-4baf-8831-71e92da75d97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_48313bf3-fafa-481e-91ad-1c4afd62ec16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_12a17a37-cdc9-4804-8558-c07e463e0551" xlink:href="jazz-20200930.xsd#jazz_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_25d36008-3d8c-4baf-8831-71e92da75d97" xlink:to="loc_jazz_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_12a17a37-cdc9-4804-8558-c07e463e0551" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItems" xlink:type="simple" xlink:href="jazz-20200930.xsd#CertainBalanceSheetItems"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItems" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsTables" xlink:type="simple" xlink:href="jazz-20200930.xsd#CertainBalanceSheetItemsTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#CertainBalanceSheetItemsPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e723e204-936f-4fcd-92db-beed24182d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a1fe30d7-55f4-47f8-b228-1a1aff9307ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e723e204-936f-4fcd-92db-beed24182d9c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a1fe30d7-55f4-47f8-b228-1a1aff9307ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_501f8f11-cd29-4e52-898d-d804ee387609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e723e204-936f-4fcd-92db-beed24182d9c" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_501f8f11-cd29-4e52-898d-d804ee387609" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#CertainBalanceSheetItemsAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedRebatesAndOtherSalesDeductions_ada0b1c1-a879-46fa-aad7-a17fc496cd1f" xlink:href="jazz-20200930.xsd#jazz_AccruedRebatesAndOtherSalesDeductions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_jazz_AccruedRebatesAndOtherSalesDeductions_ada0b1c1-a879-46fa-aad7-a17fc496cd1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_77534644-3d0a-40dd-aa94-39dda01f5061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_77534644-3d0a-40dd-aa94-39dda01f5061" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7fadfcf4-cdcd-4e70-a32a-45b109f127e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7fadfcf4-cdcd-4e70-a32a-45b109f127e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_3f18d3dc-0b5c-422d-a428-9231a39c52fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_3f18d3dc-0b5c-422d-a428-9231a39c52fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_67d8deea-585d-4d03-8b70-d34d7dc6f8b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_67d8deea-585d-4d03-8b70-d34d7dc6f8b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedInventoryRelatedLiabilities_b8bab9f7-4f1e-402e-bd77-569fd85e3518" xlink:href="jazz-20200930.xsd#jazz_AccruedInventoryRelatedLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_jazz_AccruedInventoryRelatedLiabilities_b8bab9f7-4f1e-402e-bd77-569fd85e3518" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SalesReturnReserve_ce1df438-6960-475b-b3af-4d7a37c91a43" xlink:href="jazz-20200930.xsd#jazz_SalesReturnReserve"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_jazz_SalesReturnReserve_ce1df438-6960-475b-b3af-4d7a37c91a43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedCollaborationCostsCurrent_cf7e199f-40e3-4065-957d-396b1c185363" xlink:href="jazz-20200930.xsd#jazz_AccruedCollaborationCostsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_jazz_AccruedCollaborationCostsCurrent_cf7e199f-40e3-4065-957d-396b1c185363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_a2e4a15b-fd0d-41e4-8431-5baa4f6906d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_a2e4a15b-fd0d-41e4-8431-5baa4f6906d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_c2010f99-db03-440f-9448-be836acdc7c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_c2010f99-db03-440f-9448-be836acdc7c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedInterest_11e55a56-4253-4abf-b0af-8ca8a34fd0d1" xlink:href="jazz-20200930.xsd#jazz_AccruedInterest"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_jazz_AccruedInterest_11e55a56-4253-4abf-b0af-8ca8a34fd0d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedClinicalTrialLiability_c8b7dc24-c6a8-44e6-b8cd-63362db47760" xlink:href="jazz-20200930.xsd#jazz_AccruedClinicalTrialLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_jazz_AccruedClinicalTrialLiability_c8b7dc24-c6a8-44e6-b8cd-63362db47760" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedConstructionInProgress_49351bdd-70ef-47f3-8bde-0d8e007bea07" xlink:href="jazz-20200930.xsd#jazz_AccruedConstructionInProgress"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_jazz_AccruedConstructionInProgress_49351bdd-70ef-47f3-8bde-0d8e007bea07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_871050f1-bfef-40d3-b952-5d1932fd0778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_84757e51-b0ad-4b6b-9199-53bd18c149d9" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_871050f1-bfef-40d3-b952-5d1932fd0778" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Debt" xlink:type="simple" xlink:href="jazz-20200930.xsd#Debt"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Debt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtTables" xlink:type="simple" xlink:href="jazz-20200930.xsd#DebtTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#DebtScheduleofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2c075aae-3320-4f59-90bf-39a4753c51b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f0976a26-7ff2-4c7d-9453-5016f6a33e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_2c075aae-3320-4f59-90bf-39a4753c51b0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f0976a26-7ff2-4c7d-9453-5016f6a33e23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_d48b20ac-38fd-4cfb-9bf5-45d28c895b64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_2c075aae-3320-4f59-90bf-39a4753c51b0" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_d48b20ac-38fd-4cfb-9bf5-45d28c895b64" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails_1" xlink:type="simple" xlink:href="jazz-20200930.xsd#DebtScheduleofLongtermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_db916e98-b422-4c62-aef5-7610788b3170" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f7a87f9c-cae4-417c-8bd7-1b86212b2894" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_db916e98-b422-4c62-aef5-7610788b3170" xlink:to="loc_us-gaap_LongTermDebtCurrent_f7a87f9c-cae4-417c-8bd7-1b86212b2894" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4b8d3d66-f1f5-440f-bad4-ee05892b1245" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_db916e98-b422-4c62-aef5-7610788b3170" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4b8d3d66-f1f5-440f-bad4-ee05892b1245" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#DebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#DebtScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_9dbb7dfb-4d48-45f3-8eea-158a7282d754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_08e8a3b1-1e59-4503-932c-e6531200fdd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9dbb7dfb-4d48-45f3-8eea-158a7282d754" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_08e8a3b1-1e59-4503-932c-e6531200fdd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2b5a3f45-d47d-43b3-9036-4db84ffd2259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9dbb7dfb-4d48-45f3-8eea-158a7282d754" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2b5a3f45-d47d-43b3-9036-4db84ffd2259" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_17227247-e821-4baa-a591-f4c30aaf49f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9dbb7dfb-4d48-45f3-8eea-158a7282d754" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_17227247-e821-4baa-a591-f4c30aaf49f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_43a2e29f-800c-4841-b32a-141bb61cd562" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9dbb7dfb-4d48-45f3-8eea-158a7282d754" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_43a2e29f-800c-4841-b32a-141bb61cd562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_30773906-2828-4258-bab8-295b98a0625e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9dbb7dfb-4d48-45f3-8eea-158a7282d754" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_30773906-2828-4258-bab8-295b98a0625e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LongTermDebtMaturityAfterYearFour_3df71c2b-4285-42b3-a406-0d5d034f3832" xlink:href="jazz-20200930.xsd#jazz_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_9dbb7dfb-4d48-45f3-8eea-158a7282d754" xlink:to="loc_jazz_LongTermDebtMaturityAfterYearFour_3df71c2b-4285-42b3-a406-0d5d034f3832" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Leases" xlink:type="simple" xlink:href="jazz-20200930.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="jazz-20200930.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_e1fa697f-5ea2-4e2c-b73f-eba5c28640fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_e700d23b-a85e-4053-a641-dfb96e4c296a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e1fa697f-5ea2-4e2c-b73f-eba5c28640fe" xlink:to="loc_us-gaap_OperatingLeaseCost_e700d23b-a85e-4053-a641-dfb96e4c296a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_16cfd83b-551d-4c3b-a11c-631547dc8bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e1fa697f-5ea2-4e2c-b73f-eba5c28640fe" xlink:to="loc_us-gaap_ShortTermLeaseCost_16cfd83b-551d-4c3b-a11c-631547dc8bcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_dd97c236-fbeb-46a0-b9c4-820dfa6425c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e1fa697f-5ea2-4e2c-b73f-eba5c28640fe" xlink:to="loc_us-gaap_VariableLeaseCost_dd97c236-fbeb-46a0-b9c4-820dfa6425c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_40f66660-6b63-4254-a7e5-79ab58fbf4a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e1fa697f-5ea2-4e2c-b73f-eba5c28640fe" xlink:to="loc_us-gaap_SubleaseIncome_40f66660-6b63-4254-a7e5-79ab58fbf4a9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6f7c8ceb-3594-4c7b-9c4c-2b6c0351fb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c505935b-93ce-4067-a188-6bfa42b6cc17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_6f7c8ceb-3594-4c7b-9c4c-2b6c0351fb5d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c505935b-93ce-4067-a188-6bfa42b6cc17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9ecf7c5f-e55c-4b00-a47c-eb6a400ff74a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_6f7c8ceb-3594-4c7b-9c4c-2b6c0351fb5d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9ecf7c5f-e55c-4b00-a47c-eb6a400ff74a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesWeightedAverageTermsandDiscountRatesDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#LeasesWeightedAverageTermsandDiscountRatesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesWeightedAverageTermsandDiscountRatesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e1d88bc3-6159-47c1-9b3c-17bb386f450c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a1eb9a3e-2f6f-4660-bea5-60282a73bbd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e1d88bc3-6159-47c1-9b3c-17bb386f450c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a1eb9a3e-2f6f-4660-bea5-60282a73bbd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0fc4a446-f8db-42a0-8280-008a87dcc51d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e1d88bc3-6159-47c1-9b3c-17bb386f450c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0fc4a446-f8db-42a0-8280-008a87dcc51d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_dc97b42c-847d-4838-8612-5731023aa6d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e1d88bc3-6159-47c1-9b3c-17bb386f450c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_dc97b42c-847d-4838-8612-5731023aa6d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1cf086c1-8d65-4a7d-bea9-cdab78ba9416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e1d88bc3-6159-47c1-9b3c-17bb386f450c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1cf086c1-8d65-4a7d-bea9-cdab78ba9416" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_06445e4e-16da-41e3-861d-eae09fbdceba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e1d88bc3-6159-47c1-9b3c-17bb386f450c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_06445e4e-16da-41e3-861d-eae09fbdceba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_1f90129a-9d18-418a-a221-16a5861ca28f" xlink:href="jazz-20200930.xsd#jazz_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e1d88bc3-6159-47c1-9b3c-17bb386f450c" xlink:to="loc_jazz_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_1f90129a-9d18-418a-a221-16a5861ca28f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="jazz-20200930.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0efa846-2e3a-4821-acb1-4980fdfc7789" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_785a0eb6-ea8e-4677-b76e-86d0c45adf98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0efa846-2e3a-4821-acb1-4980fdfc7789" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_785a0eb6-ea8e-4677-b76e-86d0c45adf98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_997424d9-f029-4926-ab84-e1725c1aa40c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0efa846-2e3a-4821-acb1-4980fdfc7789" xlink:to="loc_us-gaap_OperatingLeaseLiability_997424d9-f029-4926-ab84-e1725c1aa40c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="jazz-20200930.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="jazz-20200930.xsd#ShareholdersEquity"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="jazz-20200930.xsd#ShareholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityShareRepurchaseProgramsDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#ShareholdersEquityShareRepurchaseProgramsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityShareRepurchaseProgramsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#ShareholdersEquityComponentofAccumulatedOtherComprehensiveLossDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7aaf0744-ad6b-4cc3-943b-36c4d021208a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_8ea22e5e-534f-4af9-a80a-1c251a71c2e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7aaf0744-ad6b-4cc3-943b-36c4d021208a" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_8ea22e5e-534f-4af9-a80a-1c251a71c2e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_e0ecf85e-1185-4052-96e1-aff29170d791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7aaf0744-ad6b-4cc3-943b-36c4d021208a" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_e0ecf85e-1185-4052-96e1-aff29170d791" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShare" xlink:type="simple" xlink:href="jazz-20200930.xsd#NetIncomeperOrdinaryShare"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareTables" xlink:type="simple" xlink:href="jazz-20200930.xsd#NetIncomeperOrdinaryShareTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareBasicandDilutedNetIncomeperCommonShareDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#NetIncomeperOrdinaryShareBasicandDilutedNetIncomeperCommonShareDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareBasicandDilutedNetIncomeperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6d98be5-8fb7-4106-a87f-17183b24d3e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ba079a0c-3ef3-4b5e-8ebc-1071ed0a5060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6d98be5-8fb7-4106-a87f-17183b24d3e2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ba079a0c-3ef3-4b5e-8ebc-1071ed0a5060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b17dcf47-bc2f-43eb-b78f-6295e8a4cb35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6d98be5-8fb7-4106-a87f-17183b24d3e2" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b17dcf47-bc2f-43eb-b78f-6295e8a4cb35" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareWeightedAverageOrdinarySharesExcludedfromComputationofDilutedNetIncomeperShareDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#NetIncomeperOrdinaryShareWeightedAverageOrdinarySharesExcludedfromComputationofDilutedNetIncomeperShareDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareWeightedAverageOrdinarySharesExcludedfromComputationofDilutedNetIncomeperShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Revenues" xlink:type="simple" xlink:href="jazz-20200930.xsd#Revenues"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/Revenues" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesTables" xlink:type="simple" xlink:href="jazz-20200930.xsd#RevenuesTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#RevenuesSummaryofDisaggregationofRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryofDisaggregationofRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryofthePercentageofTotalRevenuesfromCustomersDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#RevenuesSummaryofthePercentageofTotalRevenuesfromCustomersDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryofthePercentageofTotalRevenuesfromCustomersDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#RevenuesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryofContractLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#RevenuesSummaryofContractLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryofContractLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="jazz-20200930.xsd#ShareBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="jazz-20200930.xsd#ShareBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#ShareBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_17c20dcf-f849-4b26-ba87-716adcffc581" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c7b398fb-3c66-4c43-9e90-1e06e130aebb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_17c20dcf-f849-4b26-ba87-716adcffc581" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c7b398fb-3c66-4c43-9e90-1e06e130aebb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d03932d6-a05a-4564-a958-976534761279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_17c20dcf-f849-4b26-ba87-716adcffc581" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d03932d6-a05a-4564-a958-976534761279" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationWeightedAverageAssumptionsandResultingGrantDateFairValueDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#ShareBasedCompensationWeightedAverageAssumptionsandResultingGrantDateFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationWeightedAverageAssumptionsandResultingGrantDateFairValueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationRestrictedUnitsDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#ShareBasedCompensationRestrictedUnitsDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationRestrictedUnitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jazz-20200930.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#IncomeTaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SubsequentEvent" xlink:type="simple" xlink:href="jazz-20200930.xsd#SubsequentEvent"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SubsequentEvent" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SubsequentEventNarrativeDetails" xlink:type="simple" xlink:href="jazz-20200930.xsd#SubsequentEventNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jazzpharma.com/role/SubsequentEventNarrativeDetails" xlink:type="extended"/>
</link:linkbase>
